Colofac 135 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

colofac 135 mg tablets

mylan ire healthcare limited - mebeverine hydrochloride - coated tablet - 135 milligram(s) - synthetic anticholinergics, esters with tertiary amino group; mebeverine

Colofac 135mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

colofac 135mg tablets

imbat limited - mebeverine hydrochloride - coated tablet - 135 milligram(s) - synthetic anticholinergics, esters with tertiary amino group

Dicycloverine hydrochloride 10mg/5ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

dicycloverine hydrochloride 10mg/5ml oral solution

syri pharma limited t/a thame laboratories - dicycloverine hydrochloride - oral solution - 10 mg/5ml - synthetic anticholinergics, esters with tertiary amino group; dicycloverine

PANTOPRAZOLE SODIUM tablet, delayed release United States - English - NLM (National Library of Medicine)

pantoprazole sodium tablet, delayed release

proficient rx lp - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole sodium delayed-release tablets, usp are indicated for: pantoprazole is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (ee). for those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. safety of treatment beyond 8 weeks in pediatric patients has not been established. pantoprazole is indicated for maintenance of healing of ee and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd. controlled studies did not extend beyond 12 months. pantoprazole is indicated for the long-term treatment of pathological hypersecretory conditions, including zollinger-ellison syndrome. pregnancy category c reproduction studies have been performed in rats at oral pantoprazole doses up to 450 mg/kg/day (about 88 times the recommended human dose based on body surface area)

COLOTAL TABLETS 135 MG Israel - English - Ministry of Health

colotal tablets 135 mg

padagis israel pharmaceuticals ltd, israel - mebeverine hydrochloride - tablets - mebeverine hydrochloride 135 mg - mebeverine - mebeverine - irritable bowel syndrome and conditions included in this group such as: chronic irritable colon, gastro- intestinal spasm secondary to organic diseases

NOTENSYL TABLETS Israel - English - Ministry of Health

notensyl tablets

cts chemical industries ltd, israel - dicyclomine hydrochloride - tablets - dicyclomine hydrochloride 10 mg - dicycloverine - dicycloverine - adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance.

DUSPATALIN RETARD CAPSULE 200 mg Singapore - English - HSA (Health Sciences Authority)

duspatalin retard capsule 200 mg

abbott laboratories (singapore ) private limited - mebeverine hcl - capsule - 200 mg - mebeverine hcl 200 mg

Colofac Malta - English - Medicines Authority

colofac

abbott healthcare products limited - mebeverine hydrochloride 135 mg - tablet

Medoverine Malta - English - Medicines Authority

medoverine

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - mebeverine hydrochloride - film-coated tablet - mebeverine hydrochloride 135 mg - drugs for functional gastrointestinal disorders

COLOFAC 135 Milligram Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

colofac 135 milligram tablets

bgp products ltd - mebeverine hydrochloride - tablets - 135 milligram - synthetic anticholinergics, esters with tertiary amino group - synthetic anticholinergics, esters with tertiary amino group - for use in the management of irritable bowel syndrome, (particularly gastrointestinal spasm).